functionalization found in ring A. The rigid core framework
of the cortistatins, with its seven-membered B ring and
challenging tetrahydrofuran heterocycle, has inspired a
growing number of creative undertakings in the area of
chemical synthesis. The laboratories of Baran,6 Nicolaou and
Chen,7 and Shair8 have achieved impressive syntheses of
the full structure of cortistatin A (1), while the groups of
Sarpong,9 Hirama,10 Danishefsky,11 Gung,12 Yang,13 Koba-
yashi,14 and Magnus15 have described conceptually interest-
ing approaches to key elements of the cortistatin structure.
Our laboratory was also drawn to the problem of synthesizing
the polycyclic ring system that distinguishes the cortistatin
class. In the course of dealing with this problem, we
discovered that the reagent [bis(acetoxy)iodo]benzene is
capable of triggering a productive double annulation that
serves the synthesis by establishing three required bonds and
two ring systems. Our construction of the pentacyclic core
framework of the cortistatins featuring this hypervalent
iodine-mediated transformation is described in this report.
In the design phase, we envisioned that the pentacyclic
core of cortistatin A might arise from three independent
cyclization events, two of which would be nitrone/alkene [3
+ 2] dipolar cycloadditions. The first dipolar cycloaddition
would accomplish a merger of fragments (2 + 3 f 4,
Scheme 1) and simultaneously construct the crowded C8-O
bond as well as the C6-C7 bond. After dismantling the
newly formed isoxazolidine ring system in 4 by an unprec-
edented type of double reduction,16 we would then elaborate
complex nitrone 5 as a prelude to the key transformation of
the synthesis. In principle, a structure of the type 5 could be
directly transformed to a cortistatin-like pentacycle (cf. 7)
by an oxidative cyclodearomatization with interception of
the resulting dienone by an intramolecular nitrone/alkene
cycloaddition (see 5 f 6 f 7); an analysis of a molecular
model of 6 suggested that such a cycloaddition should be
diastereoface-selective and facile owing to an enforced
proximity of the nitrone moiety and one of the alkenes of
the cyclic dienone. If successful, this one laboratory operation
would fashion two carbon-oxygen bonds as well as the
central B-ring of the cortistatin system. From an intermediate
of type 7, a synthesis of (+)-cortistatin A (1) would require
Scheme 1. Plan for Synthesizing (+)-Cortistatin A (1) Featuring
Two Nitrone/Alkene Cycloadditions and an Oxidative
Cyclodearomatizationa
a R ) alkyl group; P ) protecting group.
a reductive cleavage of the isoxazolidine N-O bond,
elimination of the amino function, functionalization of the
newly desymmetrized A ring, and the introduction of the
C-17 isoquinoline system.
At the outset, we favored the idea of constructing the
cortistatin core structure on the foundation provided by the
(+)-Hajos-Parrish ketone (8) (Scheme 2).17 This popular
building block for asymmetric synthesis18 comprises two
rings, both of which are expressed in the structures of the
cortistatins, and furnishes the methyl-bearing, quaternary
stereogenic center corresponding to position 13 in the goal
system. This one stereocenter was expected to direct the
stereochemical development of the entire effort. Thus, from
(+)-Hajos-Parrish ketone (8), key intermediate 2 (P ) Sit-
BuMe2) was fashioned by an improved method19 through
the following sequence of reactions (Scheme 2): (1) a site-
selective reduction of the unconjugated ketone in 8 with
sodium borohydride, (2) protection of the resulting secondary
alcohol in the form of a tert-butyldimethylsilyl ether, (3)
(5) Cee, V. J.; Chen, D. Y.-K.; Lee, M. R.; Nicolaou, K. C. Angew.
Chem., Int. Ed. [Online early access]. DOI: 10.1002/anie.200904778.
Published Online: October 20, 2009.
(6) Shenvi, R. A.; Guerrero, C. A.; Shi, J.; Li, C. C.; Baran, P. S. J. Am.
Chem. Soc. 2008, 130, 7241.
(7) (a) Nicolaou, K. C.; Sun, Y.-P.; Peng, X.-S.; Polet, D.; Chen, D. Y.-
K. Angew. Chem., Int. Ed. 2008, 47, 7310. (b) Nicolaou, K. C.; Peng, X.-
S.; Sung, Y.-P.; Polet, D.; Zou, B.; Shik, C. L.; Chen, D. D. Y.-K. J. Am.
Chem. Soc. 2009, 131, 10587.
(8) Lee, H. M.; Nieto-Oberhuber, C.; Shair, M. D. J. Am. Chem. Soc.
2008, 130, 16864.
(9) Simmons, E. M.; Hardin, A. R.; Guo, X.; Sarpong, R. Angew. Chem.,
Int. Ed. 2008, 47, 6650.
(10) Yamashita, S.; Iso, K.; Hirama, M. Org. Lett. 2008, 10, 3413.
(11) (a) Dai, M.; Danishefsky, S. J. Tetrahedron Lett. 2008, 49, 6610.
(b) Dai, M.; Wang, Z.; Danishefsky, S. J. Tetrahedron Lett. 2008, 49, 6613.
(c) Dai, M.; Danishefsky, A. Heterocycles 2009, 77, 157.
(12) Craft, D. T.; Gung, B. W. Tetrahedron Lett. 2008, 49, 5931.
(13) Liu, L.; Gao, Y.; Che, C.; Wu, N.; Wang, D. Z.; Li, C. C.; Yang,
Z. Chem. Commun. 2009, 662.
(16) N-O reduction attended by benzylic C-N hydrogenolysis is an
unprecedented transformation.
(17) (a) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615. (b)
For preparation of the Hajos-Parrish ketone, see: Org. Synth. 1990, 7, 363.
(18) For discussions of the utility of the Hajos-Parrish ketone for the
enantioselective synthesis of steroids see: Chapelon, A.-S.; Morale`da, D.;
Rodriguez, R.; Ollivier, C.; Santelli, M. Tetrahedron 2007, 63, 11511.
(14) Kotoku, N.; Sumii, Y.; Hayashi, T.; Kobayashi, M. Tetrahedron
Lett. 2008, 49, 7078.
(15) Magnus, P.; Littich, R. Org. Lett. 2009, 11, 3938.
Org. Lett., Vol. 11, No. 23, 2009
5395